The Guidelines for Cervical Screening in New Zealand, 2008 updates and replaces the Guidelines for the Management of Women with Abnormal Smears, published in 1999.
The Guidance on HPV Testing Update 1: April 2010 can be found on pg 55 of the guidelines document.
The National Screening Unit (NSU) engaged Health Outcomes International Pty Ltd (HOI) to
conduct an independent evaluation of the implementation of digital mammography (DM) at
Breast Screen Waitemata and Northland (BSWN). The overarching purpose of the evaluation was
to assist the NSU to consider options for the managed introduction of DM into the BreastScreen
Aotearoa (BSA) screening programme, and any implications for national policy and quality
standards that this introduction may have.
A key objective of the National Cervical Screening Programme (NCSP) is to reduce the incidence of cervical cancer by detecting precancerous high grade squamous intra-epithelial lesions (HSIL). Monitoring trends in HSIL detection is critical to understanding the epidemiology of cervical cancer in New Zealand and to evaluating the performance of the NCSP.